i
SUPPLEMENTARY TABLE 5. Estimated proportion of adults aged ≥19 years who received selected vaccinations, by age group, increased-risk status,* nativity, number of years living in the United States, and citizenship — National Health Interview Survey, United States, 2015
-
May 5, 2017
-
Source: Williams WW, Lu P, O’Halloran A, et al. Surveillance of Vaccination Coverage among Adult Populations — United States, 2015. MMWR Surveill Summ 2017;66(No. SS-11):1–28.
Details:
-
Journal Article:MMWR. Surveillance summaries : Morbidity and Mortality Weekly Report. Surveillance summaries
-
Description:Overall, vaccination coverage among U.S.-born respondents was significantly higher than that of foreign-born respondents except for influenza vaccination among adults aged 19-49 years and aged 50-64 years, hepatitis A vaccination among all adults aged ≥19 years and those with chronic liver conditions (where a comparison could not be made because the estimate for foreign-born respondents was suppressed), hepatitis B vaccination among adults aged ≥19 years with chronic liver conditions, adults aged ≥19 years with diabetes, adults aged 19-59 with diabetes, and adults aged ≥60 years with diabetes, and human papillomaVirus (HPV) vaccination of males (where a comparison could not be made because the estimate for foreign-born respondents was suppressed).
Vaccination coverage was higher for foreign-born persons living in the United States ≥10 years compared with those in the United States <10 years for influenza vaccination (overall for persons aged ≥19 years), pneumococcal vaccination (persons aged 19-64 years at increased risk and aged ≥65 years), and HPV vaccination (females aged 19-26 years). Vaccination coverage was significantly lower for foreign-born persons living in the United States ≥10 years compared with those living in the United States <10 years for hepatitis A and hepatitis B vaccination (adults aged ≥19 years overall and among travelers aged ≥19 years). Coverage among foreign-born adults who were U.S. citizens was higher than that for foreign-born adults who were not U.S. citizens for influenza vaccination (adults aged ≥19 years, 19-49 years, ≥65 years); tetanus vaccination (adults aged ≥19 years and 19-49 years); tetanus, diphtheria, and Acellular pertussis (Tdap) vaccination (adults aged ≥19 years and 19-64 years); hepatitis B vaccination (adults aged ≥19 years and 19-49 years); and HPV vaccination (females aged 19-26 years).
Influenza vaccination coverage was lower among adults aged 19-49 years compared with adults aged 50-64 years and ≥65 years except among foreign-born adults living in the U.S. less than 10 years, where coverage was similar by age group. Pneumococcal vaccination coverage was lower among adults aged 19-64 years at increased risk compared with adults aged ≥65 years. Compared with adults aged 19-49 years, tetanus vaccination coverage was lower among adults aged ≥65 years among U.S.-born adults and foreign-born adults who are U.S. citizens, while tetanus vaccination coverage was higher among adults aged 50-64 years among U.S.-born adults. Where comparisons could be made, Tdap coverage was lower among adults aged ≥65 years compared with adults aged 19-64 year, hepatitis B vaccination coverage among adults with diabetes aged ≥60 years was lower compared with coverage among adults aged 19-59 years with diabetes, and herpes zoster coverage among adults aged ≥65 years was higher compared with coverage among adults aged 60-64 years.
-
Source:
-
Series:
-
Document Type:
-
Genre:
-
Pages in Document:1 table
-
Volume:66
-
Issue:11
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: